SBIR/STTR Research Award
Advanced laser system for photoacoustic endomicroscopy
Award amount
$300,000Program and phase
SBIR · Phase IAward year
2016Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- LIGHT AGE, INC.
- Proposal award date
- 2016-04-12
- Contract end date
- 2017-12-31
- UEI
- Not reported
- Solicitation number
- PA15-269
- Topic code
- 102
Research abstract
DESCRIPTION provided by applicant The emerging light based imaging technique of acoustic resolution photoacoustic endomicroscopy AR PAEM enables visualization of subsurface tissues with microscopic resolution at depths of many millimeters AR PAEM images provide crucial information regarding microvasculature morphology and tissue physiology blood oxygenation For cancers originating in the epithelial tissues e g oral cavity
and pharynx and the digestive respiratory genital and urinary systems PAEM offers the potential to detect the very earliest mucosal changes at the microstructural biochemical and molecular levels by presenting subsurface tissue morphologic physiologic and cellular features This provides valuable information regarding cancer onset progression and response of to therapy Key to AR PAEM is the use of short duration nanosecond laser pulses at specific wavelengths Wavelength selective absorption by targeted tissues gives rise to a primary acoustic signal High resolution acoustic imaging is achieved by means advanced acoustic detectors and associated signal processing electronics and software Tissue discrimination is obtained from differential images at multiple deep red and near infrared wavelengths The goals of the proposed program are to develop an advanced diode pumped alexandrite laser source for clinical AR PAEM and to demonstrate its performance for bladder cancer screening and diagnostics The laser will have specialized features for achieving the imaging depth functional imaging accuracy and image acquisition time required for clinical bladder cancer screening In this Phase I program we will develop a clinical prototype laser source providing features critical for clinical AR PAEM cancer screening and diagnostics The laser will be integrated into an AR PAEM imaging system developed by the University of Michigan Pre clinical imaging studies on animal models will be performed to evaluate the benefits of the laser technology a variety of image parameters will be quantified such as imaging depth imaging speed contrast resolution and blood oxygenation This will provide an assessment of the benefits of the laser system for AR PAEM and will provide guidance for the development of a clinical pilot laser system in Phase II
PUBLIC HEALTH RELEVANCE The purpose of this program is to develop critical laser technology that enables acoustic resolution photoacoustic endomicroscopy AR PAEM to serve as a routine diagnostic tool for clinical evaluation of cancers originating in epithelial tissues g oral cavity and pharynx and the digestive respiratory genital and urinary systems Initial emphasis is placed on bladder cancer screening and diagnostics AR PAEM produces high resolution images of vasculature along with selective contrast enhancement of vascular functionality This provides valuable information regarding cancer onset progression and response to therapy Key to this is the development of specific laser performance characteristics that provide the required imaging depth image contrast and imaging speed The advanced imaging devices that result can be readily introduced into most hospitals and specialty clinics at reasonable cost and for general human benefit
Technology keywords
Not reported
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- MiREA, a mHealth intervention to Reduce Health Disparities by Improving Equitable Access to Mandated College Students with Problematic Alcohol and Marijuana Use
- Modex, a cloud-based, centralized health economic model marketplace to reduce costs and enhance equity in cancer
- Precision screening in self-collected samples to reduce cervical cancer disparities among Latinas
- Allogeneic cell and gene therapy for neuroendocrine tumors
- Nanoparticle formulation of Mediator kinase inhibitor for the treatment of peritoneal ovarian cancer